New trial shows stem cells prevent heart failure after heart attack, offering hope for cardiac recovery. Keep reading.
HF outcomes at 3 years were improved, but where stem cells fit in future research is the big unknown, says Jay Traverse.
WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary TRUSS Implant Technology™, announced the publication of a study conducted at the McKay ...
Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer The 2-year cumulative incidence of cGVHD in the MSCs group ...
The production of cell and gene therapies faces stringent regulatory requirements that demand the use of high-quality, animal ...
Intracoronary infusion of mesenchymal stem cells reduces the risk for heart failure and heart failure readmission among ...
Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study) The aim of this open-label, ...
Objective Stem cell therapy is increasingly used for knee osteoarthritis (KOA). We aimed to review the evidence of autologous mesenchymal stem cell therapy on pain, function and severity on imaging in ...
Credit: Getty Images. NurOwn consists of autologous mesenchymal stem cells that have been induced to secrete neurotrophic factors. The Food and Drug Administration (FDA)’s Cellular, Tissue and Gene ...
Metabolic reprogramming in fibrotic lung diseases involves key metabolites like lactate, succinate, and 2-hydroxyglutarate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback